Carpenter Technology Slides as Investors Continue to Digest Softer Near-Term Outlook
Investivoq PriceTracker
Carpenter Technology (CRS) is down 4.5% today. Here is some analysis on what might have caused this price movement.
Analysis: The most likely driver appears to be continued pressure from the company’s late-October earnings reaction rather than a clearly new catalyst today. While Carpenter posted record first-quarter fiscal 2027 operating income and kept its full-year outlook intact, investors seemed focused on softer second-quarter operating income guidance, recent analyst downgrades, and lower price targets.
Details:
Sources:
SEC, Carpenter Technology, Investing.com, TipRanks
Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.
$CRS Insider Trading Activity
$CRS insiders have traded $CRS stock on the open market 25 times in the past 6 months. Of those trades, 0 have been purchases and 25 have been sales.
Here’s a breakdown of recent trading of $CRS stock by insiders over the last 6 months:
- TONY R THENE (Chairman, President and CEO) has made 0 purchases and 21 sales selling 109,283 shares for an estimated $52,875,753.
- STEVEN E KAROL has made 0 purchases and 2 sales selling 5,275 shares for an estimated $2,528,096.
- RAMIN YOUNESSI sold 438 shares for an estimated $216,001
- ANASTASIOS JOHN HART sold 250 shares for an estimated $115,470
To track insider transactions, check out Investivoq's insider trading dashboard. You can access data on insider stock transactions through the Investivoq API insider transaction endpoint.
$CRS Hedge Fund Activity
We have seen 423 institutional investors add shares of $CRS stock to their portfolio, and 494 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- EGERTON CAPITAL (UK) LLP removed 1,330,920 shares (-100.0%) from their portfolio in Q2 2026, for an estimated $820,964,692
- LONE PINE CAPITAL LLC removed 855,101 shares (-47.0%) from their portfolio in Q2 2026, for an estimated $527,460,500
- AQR CAPITAL MANAGEMENT LLC added 735,006 shares (+101.5%) to their portfolio in Q2 2026, for an estimated $453,381,101
- GOLDMAN SACHS GROUP INC added 552,543 shares (+287.1%) to their portfolio in Q2 2026, for an estimated $340,830,624
- SURGOCAP PARTNERS LP removed 510,428 shares (-42.6%) from their portfolio in Q2 2026, for an estimated $314,852,407
- FMR LLC removed 488,062 shares (-11.7%) from their portfolio in Q3 2026, for an estimated $189,768,266
- SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. removed 449,556 shares (-100.0%) from their portfolio in Q3 2026, for an estimated $174,796,363
To track hedge funds' stock portfolios, check out Investivoq's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Investivoq API 13F endpoint.
$CRS Analyst Ratings
Wall Street analysts have issued reports on $CRS in the last several months. We have seen 4 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- BTIG issued a "Buy" rating on 10/23/2026
- JP Morgan issued a "Overweight" rating on 10/14/2026
- TD Cowen issued a "Buy" rating on 10/09/2026
- Susquehanna issued a "Positive" rating on 07/31/2026
To track analyst ratings and price targets for $CRS, check out Investivoq's $CRS forecast page.
$CRS Price Targets
Multiple analysts have issued price targets for $CRS recently. We have seen 7 analysts offer price targets for $CRS in the last 6 months, with a median target of $500.0.
Here are some recent targets:
- Andre Madrid from BTIG set a target price of $470.0 on 10/23/2026
- Bennett Moore from JP Morgan set a target price of $520.0 on 10/14/2026
- Gautam Khanna from TD Cowen set a target price of $500.0 on 10/09/2026
- Michael Leshock from Keybanc set a target price of $465.0 on 10/08/2026
- David Strauss from Wells Fargo set a target price of $430.0 on 09/30/2026
- Charles Minervino from Susquehanna set a target price of $600.0 on 07/31/2026
This article is not financial advice. See Investivoq's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.